A partial down-regulation of WASP is sufficient to inhibit podosome formation in dendritic cells

Molecular Therapy

Volumn 13, Issue 4, 2006, Pages 729-737

  Olivier, Aurelie ^a,c   Jeanson Leh, Laurence ^a,c   Bouma, Gerben ^b,d   Compagno, Daniel ^a,c   Blondeau, Johanna ^a,c   Seye, Khalil ^a,c   Charrier, Sabine ^a,c   Burns, Siobhan ^b,d   Thrasher, Adrian J ^b,d   Danos, Olivier ^a,c   Vainchenker, William ^a,c   Galy, Anne ^a,c  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c GÉNÉTHON   (France)

^d GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Cytoskeleton; Dendritic cells; Human; Immunology; Lentiviral vector; RNA interference; WASP

Indexed keywords

ACTIN; B7 ANTIGEN; CD86 ANTIGEN; HLA DR ANTIGEN; SHORT HAIRPIN RNA; WISKOTT ALDRICH SYNDROME PROTEIN;

3' UNTRANSLATED REGION; ARTICLE; CELL ADHESION; CELL CULTURE; CELL MATURATION; CELL MOTILITY; CELL TYPE; CONTROLLED STUDY; CYTOSKELETON; DENDRITIC CELL; DOWN REGULATION; GENE CONSTRUCT; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENE THERAPY; GENE TRANSFER; GENETIC CODE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LENTIVIRUS VECTOR; NUCLEOTIDE SEQUENCE; PHENOTYPE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SEQUENCE ANALYSIS; WESTERN BLOTTING; WISKOTT ALDRICH SYNDROME;

ANIMALIA; LENTIVIRUS;

EID: 33645511268     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2005.11.003     Document Type: Article

References (27)

1. S. Burns G.O. Cory W. Vainchenker and A.J. Thrasher Mechanisms of WASp-mediated hematologic and immunologic disease Blood 104 2004 3454-3462
2. K. Badour J. Zhang and K.A. Siminovitch The Wiskott-Aldrich syndrome protein: Forging the link between actin and cell activation Immunol. Rev. 192 2003 98-112
3. L.D. Notarangelo and H.D. Ochs Wiskott-Aldrich syndrome: A model for defective actin reorganization, cell trafficking and synapse formation Curr. Opin. Immunol. 15 2003 585-591
4. A.J. Thrasher WASp in immune-system organization and function Nat. Rev. Immunol. 2 2002 635-646
5. W. Huang H.D. Ochs B. Dupont and Y.M. Vyas The Wiskott-Aldrich syndrome protein regulates nuclear translocation of NFAT2 and NF-kappa B (RelA) independently of its role in filamentous actin polymerization and actin cytoskeletal rearrangement J. Immunol. 174 2005 2602-2611
6. J.M. Derry et. al. WASP gene mutations in Wiskott-Aldrich syndrome and X-linked thrombocytopenia Hum. Mol. Genet. 4 1995 1127-1135
7. S. Dupuis-Girod et. al. Autoimmunity in Wiskott-Aldrich syndrome: Risk factors, clinical features, and outcome in a single-center cohort of 55 patients Pediatrics 111 2003 e622-e627
8. T.S. Strom W. Gabbard P.F. Kelly J.M. Cunningham and A.W. Nienhuis Functional correction of T cells derived from patients with the Wiskott-Aldrich syndrome (WAS) by transduction with an oncoretroviral vector encoding the WAS protein Gene Ther. 10 2003 803-809
9. L. Dupre et. al. Lentiviral vector-mediated gene transfer in T cells from Wiskott-Aldrich syndrome patients leads to functional correction Mol. Ther. 10 2004 903-915
10. S. de Noronha et. al. Impaired dendritic cell homing in vivo in the absence of Wiskott-Aldrich syndrome protein Blood 105 2004 1590-1597
11. S. Burns A.J. Thrasher M.P. Blundell L. Machesky and G.E. Jones Configuration of human dendritic cell cytoskeleton by Rho GTPases, the WAS protein, and differentiation Blood 98 2001 1142-1149
12. G.E. Jones D. Zicha G.A. Dunn M. Blundell and A. Thrasher Restoration of podosomes and chemotaxis in Wiskott-Aldrich syndrome macrophages following induced expression of WASp Int. J. Biochem. Cell. Biol. 34 2002 806-815
13. S. Burns S.J. Hardy J. Buddle K.L. Yong G.E. Jones and A.J. Thrasher Maturation of DC is associated with changes in motile characteristics and adherence Cell Motil. Cytoskeleton 57 2004 118-132
14. Y. Calle H.C. Chou A.J. Thrasher and G.E. Jones Wiskott-Aldrich syndrome protein and the cytoskeletal dynamics of dendritic cells J. Pathol. 204 2004 460-469
15. S. Charrier et. al. A lentiviral vector encoding the human Wiskott-Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice Gene Ther. 12 2005 597-606
16. K. Imai et. al. Clinical course of patients with WASP gene mutations Blood 103 2004 456-464
17. G.J. Hannon RNA interference Nature 418 2002 244-251
18. T.R. Brummelkamp R. Bernards and R. Agami A system for stable expression of short interfering RNAs in mammalian cells Science 296 2002 550-553
19. T. Abbas-Terki W. Blanco-Bose N. Deglon W. Pralong and P. Aebischer Lentiviral-mediated RNA interference Hum. Gene Ther. 13 2002 2197-2201
20. D.A. Rubinson et. al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference Nat. Genet. 33 2003 401-406
21. M. Binks G.E. Jones P.M. Brickell C. Kinnon D.R. Katz and A.J. Thrasher Intrinsic dendritic cell abnormalities in Wiskott-Aldrich syndrome Eur. J. Immunol. 28 1998 3259-3267
22. P. Allavena et. al. Monocytes from Wiskott-Aldrich patients differentiate in functional mature dendritic cells with a defect in CD83 expression Eur. J. Immunol. 31 2001 3413-3421
23. A. Reynolds D. Leake Q. Boese S. Scaringe W.S. Marshall and A. Khvorova Rational siRNA design for RNA interference Nat. Biotechnol. 22 2004 326-330
24. S. Linder U. Wintergerst C. Bender-Gotze K. Schwarz U. Pannicke and M. Aepfelbacher Macrophages of patients with X-linked thrombocytopenia display an attenuated Wiskott-Aldrich syndrome phenotype Immunol. Cell Biol. 81 2003 130-136
25. G. Ferlazzo A. Wesa W.-A. Wei and A. Galy Dendritic cells generated either from CD34+ progenitor cells or from monocytes differ in their ability to activate antigen-specific CD8+ T cells J. Immunol. 163 1999 3597-3604
26. T. Dull et. al. A third-generation lentivirus vector with a conditional packaging system J. Virol. 72 1998 8463-8471
27. D. Zicha G.A. Dunn and A.F. Brown A new direct-viewing chemotaxis chamber J. Cell Sci. 99 Pt 4 1991 769-775